tiprankstipranks
Outlook Therapeutics Grants Stock Options to Top Executives
PremiumCompany AnnouncementsOutlook Therapeutics Grants Stock Options to Top Executives
1M ago
Outlook Therapeutics files to sell 21.43M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics files to sell 21.43M shares of common stock for holders
1M ago
Outlook Therapeutics Inc trading resumes
PremiumThe Fly
Outlook Therapeutics Inc trading resumes
1M ago
Outlook Therapeutics price target lowered to $1.50 from $2 at H.C. Wainwright
PremiumThe FlyOutlook Therapeutics price target lowered to $1.50 from $2 at H.C. Wainwright
2M ago
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
PremiumPress Releases
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
2M ago
Outlook Therapeutics reports Q1 EPS (4c), consensus (5c)
PremiumThe Fly
Outlook Therapeutics reports Q1 EPS (4c), consensus (5c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100